Drug Search Results
More Filters [+]

Pentosan polysulfate sodium

Alternative Names: pentosan polysulfate sodium, elmiron
Latest Update: 2024-06-21
Latest Update Note: News Article

Product Description

Pentosan polysulfate (pentosan polysulfate sodium; ELMIRON), a heparin-like, sulfated polysaccharide, is used to manage bladder pain and discomfort in adults with interstitial cystitis (IC). (Sourced from: https://pubmed.ncbi.nlm.nih.gov/16706553/)

Mechanisms of Action: NNRT Inhibitor

Novel Mechanism: No

Modality: N/A

Route of Administration: Subcutaneous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Canada | Croatia | Czech | Denmark | Dominican Republic | Egypt | Estonia | European Medicines Agency | Finland | France | Germany | Hong Kong | Hungary | Iceland | India | Ireland | Italy | Korea | Latvia | Lithuania | Netherlands | Norway | Peru | Poland | Portugal | Russia | Saudi Arabia | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: Paradigm
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pentosan polysulfate sodium

Countries in Clinic: Australia, United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Osteoarthritis, Knee

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PARA_OA_002

P3

Active, not recruiting

Osteoarthritis, Knee

2024-10-15

19%

Recent News Events